Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity (Q43766052)

26 November 2017

title

Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity (English)

1 reference

26 November 2017

1 reference

T Sharp

4

0 references

author name string

G S Dawe

1

1 reference

26 November 2017

K D Huff

2

1 reference

26 November 2017

J L Vandergriff

3

1 reference

26 November 2017

M J O'Neill

5

1 reference

26 November 2017

K Rasmussen

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

26 November 2017

published in

Biological Psychiatry

1 reference

26 November 2017

volume

50

1 reference

26 November 2017

issue

7

1 reference

26 November 2017

page(s)

510-520

1 reference

Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Immunohistochemical studies of noradrenergic-induced expression of c-fos in the rat CNS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Radioreceptor binding profile of the atypical antipsychotic olanzapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Activation of locus coeruleus neurons by peripheral stimuli: Modulation by a collateral inhibitory mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Spatially and temporally differentiated patterns of c-fos expression in brainstem catecholaminergic cell groups induced by cardiovascular challenges in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Acute haloperidol increases impulse activity of brain noradrenergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Hemodynamic stress activates locus coeruleus neurons of unanesthetized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Activation of locus coeruleus neurons by nucleus paragigantocellularis or noxious sensory stimulation is mediated by intracoerulear excitatory amino acid neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Neurochemical and electrophysiological studies on the functional significance of burst firing in serotonergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

The control of firing pattern in nigral dopamine neurons: burst firing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Receptor mechanisms mediating clozapine-inducedc-fos expression in the forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Comparative effects of sciatic nerve stimulation, blood pressure, and morphine on the activity of A5 and A6 pontine noradrenergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Distribution of dopamine-immunoreactive fibers in the rat brainstem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Bursts and recurrences of bursts in the spike trains of spontaneously active striate cortex neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Quantitative image analysis for immunocytochemistry and in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Directionally specific changes in arterial pressure induce differential patterns of fos expression in discrete areas of the rat brainstem: a double-labeling study for Fos and catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Clozapine- and olanzapine-induced Fos expression in the rat medial prefrontal cortex is mediated by beta-adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

The locus coeruleus: actions of psychoactive drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Locus coeruleus activation by physiological challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Locus coeruleus norepinephrine-containing neurons: effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Effects of olanzapine on regional C-Fos expression in rat forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Olanzapine-induced Fos expression in the rat forebrain; cross-tolerance with haloperidol and clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Effects of clozapine on the activity of central dopaminergic and noradrenergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Adrenoceptor antagonists block c-fos response to stress in the mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Schizophrenia and the frontal lobe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Prefrontal function in schizophrenia: confounds and controversies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

Negative symptoms and hypofrontality in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

c-fos expression as a marker of central cardiovascular neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(01)01171-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(01)01171-4

1 reference

26 November 2017

1 reference